| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/26/2009 | WO2009025759A1 Tight junction proteins associated with infection and entry of hepatitis c virus (hcv), methods and uses thereof |
| 02/26/2009 | WO2009025691A1 Dendrimeric peptides, pharmaceutical compositions and methods of using the same |
| 02/26/2009 | WO2009025669A1 Polymeric linkers containing pyridyl disulfide moieties |
| 02/26/2009 | WO2009025651A1 Biologically active peptide and method of using the same |
| 02/26/2009 | WO2009025300A1 Peptide capable of binding to immunoglobulin |
| 02/26/2009 | WO2009025196A1 Foxm1 peptide and medicinal agent comprising the same |
| 02/26/2009 | WO2009025117A1 Cdca1 peptide and pharmaceutical agent comprising the same |
| 02/26/2009 | WO2009025116A1 Cdh3 peptide and medicinal agent comprising the same |
| 02/26/2009 | WO2009024957A1 Materials and methods for treating or preventing organophosphate exposure associated damage |
| 02/26/2009 | WO2009024924A1 Albumin for treating cancer and a pharmaceutical composition comprising the combination of an anti-neoplastic agent and albumin |
| 02/26/2009 | WO2009024789A1 Hiv-2 antigenic peptides |
| 02/26/2009 | WO2009024763A2 Combination therapy |
| 02/26/2009 | WO2009024667A2 Antitumour combinations containing a vegf inhibiting agent and irinotecan |
| 02/26/2009 | WO2009024631A2 A combination of inhibitors of tgfbeta-1 and matrix metalloproteins for use in the treatment of bone metastases, bone resorption and hypercalcaemia |
| 02/26/2009 | WO2009024538A1 Method for preparing cells for engraftment |
| 02/26/2009 | WO2009024528A1 Use of cyclic depsipeptides to inhibit kallikrein 7 |
| 02/26/2009 | WO2009024527A1 Cyclic depsipeptides |
| 02/26/2009 | WO2009024346A2 The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases |
| 02/26/2009 | WO2009024070A1 Detection and quantitation of urine gelsolin |
| 02/26/2009 | WO2009024015A1 A stable formulation of exenatide |
| 02/26/2009 | WO2009023959A1 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 02/26/2009 | WO2009023903A1 Compositions comprising phospholipids |
| 02/26/2009 | WO2009009034A3 Methods and compositions useful in the treatment of mucositis |
| 02/26/2009 | WO2009006638A3 Peptides facilitating retrograde transport and their uses |
| 02/26/2009 | WO2009006541A3 Proteinases destroy cancer tumor's solid structure and kill cancer cells locally |
| 02/26/2009 | WO2009003493A3 Mhc multimers, methods for their generation, labeling and use |
| 02/26/2009 | WO2009002768A3 Liquid bandage |
| 02/26/2009 | WO2009002669A3 Small peptides specifically bind to colorectal cancers |
| 02/26/2009 | WO2009002437A3 Neurotoxin theraphy for postprandial hyperglycemia |
| 02/26/2009 | WO2009000929A3 Composition and method for treatment of autoimmune disease |
| 02/26/2009 | WO2008154350A3 Use of tight junction agonists to suppress immune responses |
| 02/26/2009 | WO2008154004A3 Inhibition of tumor metastases using protein kinase c (pkc) inhibitors |
| 02/26/2009 | WO2008152262A3 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system |
| 02/26/2009 | WO2008152140A3 Recombinant transferrin mutants |
| 02/26/2009 | WO2008147143A3 Immunoglobulin fusion proteins |
| 02/26/2009 | WO2008145095A3 Amino acid-mineral-peptide complex, especially quantum-mechanically modified, as a medicament for the treatment of dementia diseases |
| 02/26/2009 | WO2008144690A3 Compositions and methods for enhancing active agent absorption |
| 02/26/2009 | WO2008137834A3 Crystal structure of smyd3 protein |
| 02/26/2009 | WO2008130635A3 Formation of superfibronectin by bbk32 and uses therefor |
| 02/26/2009 | WO2008130607A3 Wound healing compositions containing keratin biomaterials |
| 02/26/2009 | WO2008127711A3 Interferons of rhesus and cynomolgus origin and uses thereof |
| 02/26/2009 | WO2008109653A3 Peptides specific for human blood outgrowth endothelial cells |
| 02/26/2009 | WO2008100288A3 High affinity ephb receptor binding compounds and methods of use thereof |
| 02/26/2009 | WO2008088581A3 Liposome treatment of viral infections |
| 02/26/2009 | WO2008084368A9 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy |
| 02/26/2009 | WO2008059041A3 Complementation of factor xi deficiency by factor v mutants |
| 02/26/2009 | WO2008059009A3 Factor v mutants for hemostasis in hemophilia |
| 02/26/2009 | WO2007146401A3 Denatured collagen peptides and uses thereof |
| 02/26/2009 | WO2005067898A3 Improved sustained release compositions for pulmonary administration of insulin |
| 02/26/2009 | WO2004096160A3 Vesicle-associated proteins |
| 02/26/2009 | US20090055942 Human Coagulation Factor VII Polypeptides |
| 02/26/2009 | US20090054720 Use of histone deacetylase inhibitors in combination with radiation for the treatment of cancer |
| 02/26/2009 | US20090054632 Hydrophobically-modified protein compositions and methods |
| 02/26/2009 | US20090054625 Recombinant protein variants |
| 02/26/2009 | US20090054367 Mycobacterial antigens expressed under low oxygen tension |
| 02/26/2009 | US20090054350 Process for the sterile concentration of collagen preparations, and collagen preparations obtained |
| 02/26/2009 | US20090054349 Peptides for Promoting Hair Growth and Improving Wrinkle and Cosmetic Compositions Comprising the same |
| 02/26/2009 | US20090054348 Bi-dentate compounds as kinase inhibitors |
| 02/26/2009 | US20090054347 Kinin b1 receptor peptide agonists and uses thereof |
| 02/26/2009 | US20090054346 Elastin production-enhancing agents |
| 02/26/2009 | US20090054345 Template-Fixed Beta-Hairpin Peptidomimetics With Protease Inhibitory Activity |
| 02/26/2009 | US20090054344 Anti-angiogenic proteins and fragments and methods of use thereof |
| 02/26/2009 | US20090054343 Methods of therapy using pharmaceutical composition for thrombin peptide derivatives |
| 02/26/2009 | US20090054342 Bioactive peptides and method of using same |
| 02/26/2009 | US20090054341 Methods of Treatment Using Exendin Peptides or GLP-1 Peptides |
| 02/26/2009 | US20090054340 Use of heat-shock protein 27 for cardiovascular disease prevention and treatment |
| 02/26/2009 | US20090054339 Novel cellular factor-containing solution compositions |
| 02/26/2009 | US20090054338 Synergisms between repartitioning and immunomodulating compounds |
| 02/26/2009 | US20090054337 Natriuretic polypeptides |
| 02/26/2009 | US20090054336 Binding Agent |
| 02/26/2009 | US20090054334 Combinatorial improvement of bifunctional drug properties |
| 02/26/2009 | US20090054333 Peptide inhibitors of cyclin-dependent kinase activity and uses thereof |
| 02/26/2009 | US20090054332 Thombopoietin peptide conjugates |
| 02/26/2009 | US20090054331 High temperature stable peptide formulation |
| 02/26/2009 | US20090054330 Novel Therapeutic Use of Viral Inflammation Modulatory Protein in Blocking Xenograft Rejection |
| 02/26/2009 | US20090054329 Composition with docosapentaenoic acid |
| 02/26/2009 | US20090054328 Reagents and Methods for Modulating Gene Expression Related to Hypertension |
| 02/26/2009 | US20090054327 Human immunodeficiency virus transactivator protein (HIV-TAT)-utrophin fusion for use in treatment of muscular disorders |
| 02/26/2009 | US20090054326 Formulations for enhanced mucosal delivery of pyy |
| 02/26/2009 | US20090054325 Compositions and methods for suppressing axonal growth inhibition |
| 02/26/2009 | US20090054324 Transcriptional Regulation of High Affitnity Ige Receptor Gamma-Chain |
| 02/26/2009 | US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT |
| 02/26/2009 | US20090054322 Polypeptides and compositions comprising same and methods of using same for treating cxcr4 associated medical conditions |
| 02/26/2009 | US20090054321 Polypeptides and use thereof |
| 02/26/2009 | US20090054320 Vesiculins |
| 02/26/2009 | US20090054319 Methods and Compositions for the Treatment of Hypertension and Gastrointestinal Disorders |
| 02/26/2009 | US20090054318 Immunopotentiating Agent |
| 02/26/2009 | US20090054317 Polyvalent inhibitors of pathogens |
| 02/26/2009 | US20090054316 Agent for control of function of antigen-presenting cell |
| 02/26/2009 | US20090054315 Counteracting Drug-Induced Obesity Using GLP-1 Agonists |
| 02/26/2009 | US20090054314 Combined use of DPP-IV inhibitors and gastrin compounds |
| 02/26/2009 | US20090054313 Method for inducing deposition and maturation of bone comprising a co-therapeutic regimen of lmp-1 and bmp-2 |
| 02/26/2009 | US20090054312 SMIPs: Small molecule inhibitors of p27 depletion in cancers and other proliferative diseases |
| 02/26/2009 | US20090054311 Novel Cyclosporin Analog Formulations |
| 02/26/2009 | US20090054310 Method for Maximizing Efficacy and Predicting and Minimizing Toxicity of Calcineurin Inhibitor Compounds |
| 02/26/2009 | US20090054309 Peptidic vasopressin receptor agonists |
| 02/26/2009 | US20090054308 administering to a patient A therapeutically effective amounts of an endothelin receptor antagonist e.g. ambrisentan, bosentan etc. and (S)-2-amino-3-(4-(2-amino-6-((R)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid to treat pulmonary hypertension |
| 02/26/2009 | US20090054307 Prophylactic and therapeutic agents and uses therefor |
| 02/26/2009 | US20090054306 which binds to cell through ligand and activated by emitted light; photosensitizer is hematoporphyrin; transport ligand is peptide; conjugate of transferrin-hematoporphyrin which destroys cancerous cells in presence of luminol; tissue targeted |
| 02/26/2009 | US20090054305 Mixtures of Amylin and Insulin |